These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

911 related articles for article (PubMed ID: 18805019)

  • 1. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of stage I nonseminomatous testicular germ cell tumors.
    Pectasides D; Farmakis D; Pectasides M
    Oncology; 2006; 71(3-4):151-8. PubMed ID: 17646698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A; Pfister D
    Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Klein EA
    BJU Int; 2009 Nov; 104(9 Pt B):1362-8. PubMed ID: 19840014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of localized germ-cell tumours of the testis].
    Loriot Y; Fizazi K
    Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for stage II nonseminomatous germ cell tumors.
    Kondagunta GV; Motzer RJ
    Urol Clin North Am; 2007 May; 34(2):179-85; abstract ix. PubMed ID: 17484923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
    J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of clinical stage I nonseminomatous germ cell testicular cancer.
    Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
    Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage I testicular cancer.
    Scholz M; Höltl W
    Curr Opin Urol; 2003 Nov; 13(6):473-6. PubMed ID: 14560141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
    Stephenson AJ; Bosl GJ; Bajorin DF; Stasi J; Motzer RJ; Sheinfeld J
    J Urol; 2005 Aug; 174(2):557-60; discussion 560. PubMed ID: 16006891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
    Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
    BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of clinical stage I nonseminomatous germ-cell testis tumors.
    Flechon A; Droz JP
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):21-30. PubMed ID: 12597346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
    Kuczyk MA; Bokemeyer C; Serth J; Machtens S; Höfner K; Jonas U
    Urologe A; 1996 Jan; 35(1):35-45. PubMed ID: 8851847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of non-seminomatous germ cell tumors of the testes].
    Kawai K; Akaza H
    Gan To Kagaku Ryoho; 2000 Apr; 27(4):522-9. PubMed ID: 10790993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update.
    Yoon GH; Stein JP; Skinner DG
    Urol Oncol; 2005; 23(3):168-77. PubMed ID: 15907716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.